Related Experiment Video
Updated: Feb 14, 2026

Generation of Prostate Cancer Cell Models of Resistance to the Anti-mitotic Agent Docetaxel
Published on: September 8, 2017
Targeting FANCD2 to overcome enzalutamide resistance in prostate cancer
Wenzhen Shi1, Juliang Yang2, Yue Xu1
1Department of Urology, Fujian Medical University Union Hospital, Fuzhou, Fujian, 350000, China.
No abstract available in PubMed .
More Related Videos
07:25A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer
Published on: March 6, 2018
06:54MR Molecular Imaging of Prostate Cancer with a Small Molecular CLT1 Peptide Targeted Contrast Agent
Published on: September 3, 2013
Related Concept Videos
Treatment Resistant Cancers
Targeted Cancer Therapies
There are several types of targeted therapies against...
Bioavailability Enhancement: Determination and Conceptual Approaches in Overcoming Bioavailability Problems
Resistivity
Resistance
Equivalent Resistance